Indikativer IPO-Zeitplan
|
|
- Edwin Scott
- 6 years ago
- Views:
Transcription
1 Week Date Firma xy Investment Bank 24 Mo 25. Jul 07 Di 26. Jul Kick-off Meeting Mi 27. Jul 07 Meeting Information Memorandum Do 28. Jul 07 Fr 29. Jul 07 Sa 30. Jul 07 So 31. Jul Mo 01. Aug 07 Di 02. Aug 07 Mi 03. Aug 07 Preparation of Fact Book (Investment Bank) Do 04. Aug 07 Fr 05. Aug 07 Sa 06. Aug 07 Distribution of 1st Draft So 07. Aug Mo 08. Aug 07 Di 09. Aug 07 Mi 10. Aug 07 Do 11. Aug 07 Fr 12. Aug 07 Distribution of 2 nd Draft Sa 13. Aug 07 So 14. Aug Mo 15. Aug Fact Book Review Meeting Di 16. Aug 07 Revision of Fact Book Mi 17. Aug 07 Do 18. Aug 07 Fr 19. Aug 07 Distribution of 3 rd and Final Version Sa 20. Aug 07 So 21. Aug Mo 22. Aug 07 Distribution to Investment Banks according to Final List Di 23. Aug 07 Mi 24. Aug 07 Do 25. Aug 07 Fr 26. Aug 07 Sa 27. Aug 07 So 28. Aug Mo 29. Aug 07 Di 30. Aug 07 Mi 31. Aug 07 Do 01. Sep 07 Fr 02. Sep 07 Sa 03. Sep 07 So 04. Sep Mo 05. Sep 07 Management Presentations and Discussions with Interested Parties Di 06. Sep 07 Mi 07. Sep 07 Do 08. Sep 07 Fr 09. Sep 07 Sa 10. Sep 07 So 11. Sep Mo 12. Sep 07 1 Zeitplan, Stand
2 Week Date Firma xy Investment Bank Di 13. Sep 07 Mi 14. Sep 07 Do 15. Sep 07 Fr 16. Sep 07 Sa 17. Sep 07 So 18. Sep Mo 19. Sep 07 Di 20. Sep 07 Mi 21. Sep 07 Do 22. Sep 07 Fr 23. Sep 07 Sa 24. Sep 07 So 25. Sep Mo 26. Sep 07 Di 27. Sep 07 Mi 28. Sep 07 Do 29. Sep 07 Fr 30. Sep 07 Sa 01. Okt 07 So 02. Okt Mo 03. Okt 07 Di 04. Okt 07 Mi 05. Okt 07 Do 06. Okt 07 Fr 07. Okt 07 Sa 08. Okt 07 So 09. Okt Mo 10. Okt 07 Draft of Letter of Engagement from Underwriting Bank Draft of Letter of Engagement from Underwriting Bank Di 11. Okt 07 Mi 12. Okt 07 Do 13. Okt 07 Fr 14. Okt 07 Signing of LOE with Underwriting Bank Signing of LOE with Underwriting Bank Sa 15. Okt 07 So 16. Okt Mo 17. Okt 07 Invitation of Investor Relations Firms Invitation of Investor Relations Firms Di 18. Okt 07 Mi 19. Okt 07 Do 20. Okt 07 Decision on Auditing Company for Due Diligence Decision on Auditing Company for Due Diligence Fr 21. Okt 07 Sa 22. Okt 07 So 23. Okt Mo 18. Okt 07 Start Preparation of Offering Circular Start Preparation of Offering Circular Di 19. Okt 07 Mi 20. Okt 07 Kick-off Meeting financial und legal DD Kick-off Meeting financial und legal DD Do 21. Okt 07 Fr 22. Okt 07 Sa 23. Okt 07 So 24. Okt Mo 25. Okt 07 Consolidated Audited Annual Reports 2004/05/06 according to HGB Di 26. Okt 07 Mi 27. Okt 07 Beginning of financial and legal Due Diligence Beginning of financial and legal Due Diligence 2 Zeitplan, Stand
3 Week Date Firma xy Investment Bank Do 28. Okt 07 Fr 29. Okt 07 Selection of Investor Relations Firm Selection of Investor Relations Firm Sa 30. Okt 07 So 31. Okt Mo 01. Nov 07 Di 02. Nov 07 Mi 03. Nov 07 Do 04. Nov 07 Fr 05. Nov 07 Start Preparation of Stock Option Scheme Start Preparation of Stock Option Scheme Sa 06. Nov 07 So 07. Nov Mo 08. Nov 07 first results of Due Diligence first results of Due Diligence Di 09. Nov 07 Mi 10. Nov 07 Do 11. Nov 07 Fr 12. Nov 07 Sa 13. Nov 07 So 14. Nov Mo 15. Nov 07 Di 16. Nov 07 Mi 17. Nov 07 Do 18. Nov 07 Fr 19. Nov Draft of Stock Options Scheme 1. Draft of Stock Options Scheme Sa 20. Nov 07 So 21. Nov Mo 22. Nov Draft of Offering Circular 1. Draft of Offering Circular Di 23. Nov 07 Mi 24. Nov 07 Do 25. Nov 07 Fr 26. Nov 07 Sa 27. Nov 07 So 28. Nov Mo 29. Nov 07 Filing of admission proposal with German Stock Exchange Di 30. Nov Discussion on Draft of Offering Circular 1. Discussion on Draft of Offering Circular Mi 01. Dez 07 Do 02. Dez 07 Fr 03. Dez 07 Sa 04. Dez 07 So 05. Dez Mo 06. Dez 07 Start of talks with other underwriting banks to form consortium Start of talks with other underwriting banks to form consortium Di 07. Dez 07 Mi 08. Dez Draft of Offering Circular 2. Draft of Offering Circular Do 09. Dez 07 Fr 10. Dez 07 latest date for Reviewed Consolidated Interim Results Report Waterkotte according to HGB latest date for Reviewed Consolidated Interim Results Report Waterkotte according to HGB Sa 11. Dez 07 So 12. Dez Mo 13. Dez 07 Di 14. Dez 07 Meeting and Discussion on 2. Draft Offering Circular Meeting and Discussion on 2. Draft Offering Circular 3 Zeitplan, Stand
4 Week Date Firma xy Investment Bank Mi 15. Dez 07 Final Version of Stock Options Scheme Final Version of Stock Options Scheme Do 16. Dez 07 Fr 17. Dez 07 Draft of Due Diligence-report Draft of Due Diligence-report Sa 18. Dez 07 So 19. Dez Mo 20. Dez 07 Shareholders Meeting: Implementation of Stock Options, Capital Increase for IPO free float, "allowed(genehmigtes) capital"', Control Agreement Invitation of possible Underwriting Banks Shareholders Meeting: Implementation of Stock Options, Capital Increase for IPO free float, "allowed(genehmigtes) capital"', Control Agreement Di 21. Dez 07 Research-Briefing/Sales Briefing Research-Briefing/Sales Briefing Mi 22. Dez 07 Last Discussion of Final Version of Offering Circular Last Discussion of Final Version of Offering Circular Do 23. Dez 07 Start of Discussion on Underwriting Agreement between Start of Discussion on Underwriting Agreement between Underwriting Bank and Underwriting Bank and Waterkotte Waterkotte Fr 24. Dez 07 Final Version of Due Diligence Report Final Version of Due Diligence Report Sa 25. Dez 07 So 26. Dez Mo 27. Dez 07 Filing of Offering Circular with Stock Exchange, Start Admission Procedure Di 28. Dez 07 Mi 29. Dez 07 Do 30. Dez 07 Fr 31. Dez 07 Sa 01. Jan 08 So 02. Jan Mo 03. Jan 08 Di 04. Jan 08 Mi 05. Jan 08 Do 06. Jan 08 Fr 07. Jan 08 Sa 08. Jan 08 So 09. Jan Mo 10. Jan 08 Beginning of Press Meeting and Interviews Beginning of Press Meeting and Interviews Di 11. Jan 08 Mi 12. Jan 08 Do 13. Jan 08 Fr 14. Jan 08 Sa 15. Jan 08 So 16. Jan Mo 17. Jan 08 Di 18. Jan 08 Approval of Offering Circular by Stock Exchange Approval of Offering Circular by Stock Exchange Mi 19. Jan 08 Invitation to Press Conference/DVFA(German Association of Financial Analysts)/Investors Confeference Do 20. Jan 08 Fr 21. Jan 08 Sa 22. Jan 08 Invitation to Press Conference/DVFA(German Association of Financial Analysts)/Investors Confeference 4 Zeitplan, Stand
5 Week Date Firma xy Investment Bank So 23. Jan Mo 24. Jan 08 Beginning of Pre-Marketing, in the following days press and investor interviews Beginning of Pre-Marketing, in rthe following days press and investor interviews Di 25. Jan 08 Publication of Offering Circular in the "Börsenzeitung" Publication of Offering Circular in the "Börsenzeitung" Mi 26. Jan 08 Filing of Capital Increase for the IPO Free Float after Confimation of Paying 25% of nominal capital increase by underwriting bank with the register of commerce Do 27. Jan 08 Signing of Underwriting and Placement Agreement with Underwriting Bank Filing of Capital Increase for the IPO Free Float after Confimation of Paying 25% of nominal capital increase by underwriting bank with the register of commerce Signing of Underwriting and Placement Agreement with Underwriting Bank Fixation of Bookbuilding Range Fixation of Bookbuilding Range Fr 28. Jan 08 End of Pre-Marketing End of Pre-Marketing Sa 29. Jan 08 Publication of Share Offering and first supplement to the Offering Circular with the bookbuilding range in the "Börsenzeitung" So 30. Jan Mo 31. Jan 08 Press Conference Press Conference Press Release Bookbuilding Range Press Release Bookbuilding Range Begining of Bookbuilding Begining of Bookbuilding DVFA-/ Investors-Conference DVFA-/ Investors-Conference Di 01. Feb 08 One-to-one Meetings with Investors One-to-one Meetings with Investors Mi 02. Feb 08 One-to-one Meetings with Investors One-to-one Meetings with Investors latest date: Written Confirmation of registration of Capital Increase for IPO Free Float at the register of commerce Do 03. Feb 08 One-to-one Meetings with Investors latest date: confirmation of admission to Frankfurt Stock Exchange Payment of outstanding 75% of capital increase for IPO free float latest date: Written Confirmation of registration of Capital Increase for IPO Free Float at the register of commerce One-to-one Meetings with Investors latest date: confirmation of admission to Frankfurt Stock Exchange Payment of outstanding 75% of capital increase for IPO free float Fr 04. Feb 08 End of Bookbuilding Fixing of Issue Price End of Bookbuilding Fixing of Issue Price Sa 05. Feb 08 Publication of completed Offering Circular on the "Börsenzeitung" Publication of completed Offering Circular on the "Börsenzeitung" So 06. Feb Mo 07. Feb 08 Distribution of Shares Press release regarding the issue price Distribution of Shares Press release regarding the issue price Di 08. Feb 08 Issue of Shares Start of Greenshoe Option Issue of Shares Start of Greenshoe Option Mi 09. Feb 08 Do 10. Feb 08 Fr 11. Feb 08 Sa 12. Feb 08 So 13. Feb 08 5 Zeitplan, Stand
6 Research Investment Bank/Consortium Bank 6 Zeitplan, Stand
7 Research Investment Bank/Consortium Bank 7 Zeitplan, Stand
8 Research Investment Bank/Consortium Bank 8 Zeitplan, Stand
9 Research Investment Bank/Consortium Bank Research-Briefing/Sales Briefing Final Version of IPO-Study of Waterkotte Printing of IPO-Study Printed Version of IPO-Study finished 9 Zeitplan, Stand
10 Research Investment Bank/Consortium Bank 10 Zeitplan, Stand
Industry experience in consortium i.e. from BEE party or non-bee partners
A. ENTREPRENEURSHIP FINANCE Imbewu Entrepreneurship Finance would provides risk capital to new businesses and to early stage businesses owned and managed by black people meeting the following criteria:
More informationExperience report from the first year of working within the new regulatory environment: Germany
AGAH - Annual Meeting 2005 - Club hase 1 Early Drug Development Scientific and Regulatory Challenges Session II: Implications of the new EU-directive on clinical trials Experience report from the first
More informationEDINBURGH HEALTHCARE NHS TRUST. 4 Edinburgh Healthcare NHS Trust Printed Material,
Introduction 1 Board Minutes and Papers, 1994-1999 2 Related Board Papers, 1995-2001 3 Administrative Material, 1997-2001, n.d. 4 Edinburgh Healthcare NHS Trust Printed Material, 1995-1997 5 General Strategy
More informationFGSZ Zrt. from 28 February 2019 till 29 February 2020 AUCTION CALENDAR: YEARLY YEARLY BUNDLED AT CROSS BORDER POINTS
AUCTION CALENDAR: YEARLY YEARLY BUNDLED AT CROSS BORDER POINTS FIRM CAPACITY - First Monday of July 01.06.2019* 01.07.2019 07:00 01.10.2019 04:00 01.10.2020 04:00 2019/2020 01.10.2020 04:00 01.10.2021
More informationPRICE DEMERS & CO. Barristers, Solicitors & Notaries Public
PRICE DEMERS & CO. Barristers, Solicitors & Notaries Public Incorporation of BVI Business Companies under the BVI Business Companies Act, 2004 1. Introduction The following is a brief summary of the main
More informationHow do students study in Nuremberg?
L E H R S T U H L F U R SOZIOLOGIE Knut Wenzig How do students study in Nuremberg? A statistical analysis Krakow, October 5, 2001 Motivation discussion about future of public services effectiveness, efficiency
More informationRULES OF CONDUCT OF INSIDERS RESPECTING
T RULES OF CONDUCT OF INSIDERS RESPECTING RADING O F SECURITIES OF TFI International lnc. Amended and restated July 2015 Executive Summary As an insider of TFI International Inc. ( TFI International )
More informationEnergy efficiency and renewable options for dairy farms
Energy efficiency and renewable options for dairy farms Michael Breen Teagasc Moorepark Cork IT John Upton Teagasc Moorepark Contents Overview of energy research Milk cooling and water heating on dairy
More informationHIV POSITIVE YOUTH: LINKAGE & RETENTION IN CARE
HIV POSITIVE YOUTH: LINKAGE & RETENTION IN CARE Site C Youth clinic HIV care pathway DAY 1 Test HIV + PIMA point of care CD4 count in in 3-5 days initiation + in session 3 session 4 1 month Youth Club
More informationHarpenden Consortium Calendar
Harpenden Consortium Calendar 2018-2019 WK Roundwood SJL St George's 1 Mon 03-Sep INSET DAY INSET DAY (Staff). Yr 12 A Level Maths Aptitude Test (pm) Tues 04-Sep Start of term + Photos Yr 12 Induction
More informationCancer Biology and Immunology. Sponsorship CANCER BIOLOGY rd World Congress on. Don t count the days make the Days Count
CANCER BIOLOGY 2019 Sponsorship March 11-12, 2019 Milan, Italy 3 rd World Congress on Cancer Biology and Immunology Don t count the days make the Days Count http://cancerbiology.immunologycongress.org/
More informationARUBA RECENT ECONOMIC DEVELOPMENTS AND OUTLOOK. Presented by Jane R. Semeleer President Centrale Bank van Aruba May 30, 2011
ARUBA RECENT ECONOMIC DEVELOPMENTS AND OUTLOOK Presented by Jane R. Semeleer President Centrale Bank van Aruba May 30, 2011 STRUCTURE 1. National economy 2. International economy 3. Outlook 2 CENTRALE
More informationOperational Efficiency:
Operational Efficiency: metrics that matter Copyright Altus Ltd 214. All rights reserved. Kevin Okell Consultancy Director 15/5/214 From distribution chain to value chain Ad-valorem pricing driven from
More informationInvestor Presentation
Investor Presentation February 2018 2 FORWARD-LOOKING INFORMATION The following presentation contains statements that are considered forward-looking information ( FLI ) within the meaning of securities
More informationDIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM
November 28, 2017 DIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM Dr. Jürgen Wunram Agenda Diebold Nixdorf AG History and shareholder structure Market trends, strategy and progress of integration Diebold Nixdorf
More informationCost projections a single antiretroviral co-payment scheme for people with HIV in NSW. March 2013
Cost projections a single antiretroviral co-payment scheme for people with HIV in NSW March 2013 Background The first meeting of HIV Strategy Implementation Taskforce Committee endorsed a policy position
More informationChanges to the National Diabetes Services Scheme (NDSS)
Changes to the National Diabetes Services Scheme (NDSS) June 2016 FREQUENTLY ASKED QUESTIONS 1. What are the changes from 1 July 2016? 2. Why are the supply changes happening? 3. What is the role of Diabetes
More informationFamily Tariff. General Tariff Information. Scope of the family referral. Extended Services
F a mi l yt a r i ff Family Tariff General Tariff Information This chapter of LSS Tariffs provides information about how LSS will compensate you for family law services that you provide to clients. For
More informationMan Therapy Interim Evaluation Results to 31 December Interim results of the independent evaluation by Ipsos Social Research Institute
Man Therapy Interim Evaluation Results to 31 December 2013 Interim results of the independent evaluation by Ipsos Social Research Institute Campaign engagement Google Analytics to 2 Jan 2014 over 350,000
More informationThe Interpreting Marketplace
The Interpreting Marketplace By Nataly Kelly, Robert G. Stewart, and Vijayalaxmi Hegde June 2010 The Interpreting Marketplace By Nataly Kelly, Robert G. Stewart, and Vijayalaxmi Hegde June 2010 ISBN 978-1-933555-82-9
More informationNektar Investor & Analyst Call. Nektar & z Bristol-Myers Squibb Collaboration. February 14, 2018
Nektar Investor & Analyst Call Nektar & z Bristol-Myers Squibb Collaboration February 14, 2018 This presentation includes forward-looking statements regarding Nektar s proprietary drug candidates, the
More informationMINUTES OF THE ANNUAL SOLVAY S.A. SHAREHOLDERS MEETING On Tuesday, May 10, 2016 at 10:30 a.m.
MINUTES OF THE ANNUAL SOLVAY S.A. SHAREHOLDERS MEETING On Tuesday, May 10, 2016 at 10:30 a.m. The shareholders of the company Solvay S.A. with its corporate offices in Brussels, rue de Ransbeek, no. 310,
More informationInterim Report 1 January September 2017
2014-01-01 2014-12 Interim Report 1 January 2017 30 September 2017 Cantargia AB 556791-6019 Cantargia refers to Cantargia AB (publ), corporate ID number 556791-6019. Clinical trial initiated Highlights
More informationBluetongue in the Federal Republic of Germany. final report. SCOFCAH, Brussels, January 2012
Bluetongue in the Federal Republic of Germany final report SCOFCAH, Brussels, 11-12 January 2012 1 Overview 1. Epidemiological situation 2. Vaccination 3. Monitoring 3.1 Bovine 3.2 Sheep, goats, 3.3. wild
More informationSumitomo Pharmaceuticals reaches a basic agreement to merge with Dainippon Pharmaceutical
For immediate release November 25, 2004 Sumitomo Pharmaceuticals reaches a basic agreement to merge with Dainippon Pharmaceutical Sumitomo Chemical Co., Ltd. announced today that its subsidiary, Sumitomo
More informationEuropean but not EU the special case of ESM and EFSF
European but not EU the special case of ESM and EFSF 14 October 2014 Kalin Anev Janse Member of the Management Board Secretary General ESM and EFSF 2 What are the ESM and EFSF? ESM founded in 2012 (EFSF
More informationBVI Limited Partnership Hedge Funds: Calling Japan
BERMUDA BRITISH VIRGIN ISLANDS CAYMAN ISLANDS CYPRUS DUBAI HONG KONG LONDON MAURITIUS MOSCOW SÃO PAULO SINGAPORE conyersdill.com June 2012 BVI Limited Partnership Hedge Funds: Calling Japan Structuring
More informationImproving the lives of people with neurological conditions. Annual General Meeting Neurotech International Limited (ASX: NTI) November 2017
Improving the lives of people with neurological conditions Annual General Meeting Neurotech International Limited (ASX: NTI) November 2017 Neurotech Overview Medical device company, focussed on the development
More informationSouth Plains Emergency Medical Services, Inc. P.O. Box Lubbock, Texas 79453
South Plains Emergency Medical Services, Inc. P.O. Box 53597 Lubbock, Texas 79453 June 28, 2017 TO: SPEMS EMS Services SUBJECT: SPEMS PARAMEDIC PROTOCOL VARIANCE With the ongoing medication shortages,
More informationBetter Diagnostics for Life
NASDAQ: NMRD Better Diagnostics for Life Corporate Presentation November 2018 Forward-Looking Statement This presentation includes forward-looking statements that are subject to many risks and uncertainties.
More informationNATIONAL BANK OF POLAND
NATIONAL BANK OF POLAND RECENT TRENDS IN THE REAL ESTATE MARKET INTERNATIONAL CONFERENCE THE HOUSING PRICES IN ROMANIA - recent developments - Ph.D. Andrei RĂDULESCU Senior Economist Researcher, IWE, Romanian
More informationCancer Immunotherapy Pilot Program/ Patents 4 Patients. USPTO BCP Customer Partnership Meeting Alexandria, VA August 2, 2017
Cancer Immunotherapy Pilot Program/ Patents 4 Patients USPTO BCP Customer Partnership Meeting Alexandria, VA August 2, 2017 1 Cancer Immunotherapy Pilot Program/ Patents 4 Patients The United States Patent
More informationIMPLEMENTING RECOVERY ORIENTED CLINICAL SERVICES IN OPIOID TREATMENT PROGRAMS PILOT UPDATE. A Clinical Quality Improvement Program
IMPLEMENTING RECOVERY ORIENTED CLINICAL SERVICES IN OPIOID TREATMENT PROGRAMS PILOT UPDATE A Clinical Quality Improvement Program Today: National completion rates for OTP s hover between 11 14% Retention
More informationH. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review
H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review BioPortfolio has been marketing business and market research reports
More informationSUMMARY TERM SHEET. Sl. Particulars Details 1. Issuer L&T Finance Holdings Limited (the Company / the Issuer / L&TFHL )
SUMMARY TERM SHEET Sl. Particulars Details 1. Issuer L&T Finance Holdings Limited (the Company / the Issuer / L&TFHL ) 2. Date of resolution May 28, 2014 passed by the Board of Directors authorizing the
More informationTotal Face Group Limited
Total Face Group Limited 2017 Half Year Results Presentation Contents Results Highlights Highlights Half Year Results Revenue Bridge Revenue Breakdown Clinic Profitability Profit & Loss Financial Position
More information1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes
1Q 2015 Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes Forward-Looking Statements and Copyright This Presentation includes and is based, inter alia, on forward-looking information and statements
More informationDry Needling (DN) Registration
Dry Needling (DN) Registration To register for any of our programs, please complete the enclosed registration form (next page) and mail of fax the form to us. Fees Cost of the DN 1-3 courses is US $895
More informationI. Introduction. A. My name is Scott Russell. I am a Specialist with the Structuring and Origination
Russell Tooman / I. Introduction Q. Please state your names and positions with PGE. My name is Scott Russell. I am a Specialist with the Structuring and Origination Department at PGE. My name is Alex Tooman.
More informationTRANSFORMING STROKE CARE IN THE CAPITAL: THE LONDON STROKE STRATEGY
TRANSFORMING STROKE CARE IN THE CAPITAL: THE LONDON STROKE STRATEGY LUCY GROTHIER Director South London Cardiac and Stroke Network lucy.grothier@slcsn.nhs.uk 27 th May 2011 Gaps in London stroke care GAPS
More informationFor personal use only
ASX ANNOUNCEMENT 22 NOVEMBER 2017 AGM ADDRESSES FROM THE CHAIRMAN & CEO 22 November 2017 Cann Group Limited (ASX: CAN) is pleased to provide the following addresses to be delivered by its Chairman Allan
More informationSeventh meeting of the Forum 21 st September 2016 Paul Smith. Governance of the Strategy Implementation
Seventh meeting of the Forum 21 st September 2016 Paul Smith Governance of the Strategy Implementation Objectives and structure of this presentation To set out our preliminary view on governance of the
More informationDainippon Pharmaceutical and Sumitomo Pharmaceuticals Finalize Merger Agreement
For immediate release April 28, 2005 Dainippon Pharmaceutical and Sumitomo Pharmaceuticals Finalize Merger Agreement Dainippon Pharmaceutical Co., Ltd. Sumitomo Pharmaceuticals Co., Ltd. Dainippon Pharmaceutical
More informationSuccessful Falls Prevention in Aged Persons Mental Health. Reducing the risk and decreasing severity of outcome
Successful Falls Prevention in Aged Persons Mental Health Reducing the risk and decreasing severity of outcome Vahitha Koshy Seema Dua Elda Kimberlee Introduction Unit 3- Acute Aged Mental Health inpatient
More informationOverview of the Radiation Exposure Doses of the Workers at Fukushima Daiichi Nuclear Power Station
Click here for the corrections made < Reference > December 3, 212 Tokyo Electric Power Company Overview of the Radiation Exposure Doses of the Workers at Fukushima Daiichi Nuclear Power Station * As of
More informationProfessional Development: proposals for assuring the continuing fitness to practise of osteopaths. draft Peer Discussion Review Guidelines
5 Continuing Professional Development: proposals for assuring the continuing fitness to practise of osteopaths draft Peer Discussion Review Guidelines February January 2015 2 draft Peer Discussion Review
More informationartnet AG Quarterly Interim Statement for the First Quarter of 2016 artnet AG Quarterly Interim Statement for the First Quarter of 2016
Quarterly Interim Statement for the First Quarter of 2016 Quarterly Interim Statement for the First Quarter of 2016 for Table of Contents General Information and Business Activities Economic Development
More informationMiFID Suitability Requirements Peer Review Report - Annex
MiFID Suitability Requirements Peer Review Report - Annex 7 April 2016 ESMA/2016/585 Section 1: Questionnaire findings 1. Background information 1. This section contains information on the number of investment
More informationPORTFOLIO UNIT COST (C$) BOOK VALUE (C$) PRICE UNITS MARKET VALUE (C$) MFABC SHORT TRM BOND ,265, ,926, ,265,266.
ACCOUNT STATEMENT CITY OF WEST VANCOUVER September 30, 2015 Account #: 200000196-20 Cross-reference #: 875-1 Account Type: Non-Registered ACCOUNT SUMMARY AS OF SEPTEMBER 30, 2015 PORTFOLIO UNIT COST (C$)
More informationOctober 2013 Mo Tu We Th Fr Sa Su
October 2013 October 2013 1 2 3 4 5 6 28 29 30 31 November 2013 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 30 Sep - 6 Oct 7-13 Oct 30 Sep 1 Oct 2 3 4 5 6 12:45 new
More informationSmart Campaign Certification Standards
Smart Campaign Certification Standards January 2013 ww Client Protection Certification standards describe where the microfinance industry sets the bar in terms of client protection. To be Certified, a
More informationZacks Small-Cap Research
Zacks Small-Cap Research Sponsored Impartial - Comprehensive August 29, 2018 David Bautz, PhD 312-265-9471 dbautz@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Opiant Pharmaceuticals,
More informationPrison-Based Therapeutic Community Treatment: The California Experience
Prison-Based Therapeutic Community Treatment: The California Experience Michael L. Prendergast, Ph.D. Criminal Justice Research Group UCLA Integrated Substance Abuse Programs Overview Partnerships in the
More informationOSCR ANNUAL REVIEW Charities you can trust and that provide public benefit
OSCR ANNUAL REVIEW -14 Charities you can trust and that provide public benefit OUR IMPACT We have had another busy and productive year supporting and monitoring the country s 23,700 charities. Our volume
More informationSponsorship Levels & Benefits
Sponsorship Levels & Benefits Presented by: Rosette, LLP American Indian Economic Development Program Fifth Annual Tribal Government E-Commerce Conference To increase your visibility, sponsor a conference
More informationUroplasty, Inc. Investor Update Canaccord Genuity Conference December 6, 2011
Uroplasty, Inc. Investor Update Canaccord Genuity Conference December 6, 2011 Forward Looking Statement This presentation includes forward-looking statements, including financial projections, relating
More informationQUESTIONNAIRE ANTI MONEY LAUNDERING (Including Counter Terrorist Financing, Financial Sanctions Monitoring, KYC)
QUESTIOAIRE ATI MOE LAUDERIG (Including Counter Terrorist Financing, Financial Sanctions Monitoring, KC) Please respond to the following questionnaire by filling the columns with appropriate details or
More informationLEAD THE CHANGE. Sponsorship Opportunities. Women in Philanthropy and Leadership for Coastal Carolina University presents
Women in Philanthropy and Leadership for Coastal Carolina University presents LEAD THE CHANGE 6th Annual Women s Leadership Conference & Celebration of Inspiring Women February 10-11, 2016 Myrtle Beach,
More informationSTI in young people, the Swedish experience. Sexual Health Forum Brussels, 13 January Monica Ideström Senior Programme Officer, PhD
STI in young people, the Swedish experience Sexual Health Forum Brussels, 13 January 2010 Monica Ideström Senior Programme Officer, PhD Chlamydia in Sweden 1990-2008 Chlamydia in Sweden Sweden has an ongoing
More information(In chronological order, provide work, volunteer, community service information after earning your initial dental degree)
NOTE For the Dental Curriculum Vitae (CV), provide information on your educational credentials and dental experience starting after your initial dental degree. Please classify your dental experience by
More informationMARCH 2014 RESULTS PRESENTATION Madrid, 2014
MARCH 2014 RESULTS PRESENTATION Madrid, 2014 Disclaimer In addition to figures prepared in accordance with IFRS, PRISA presents non-gaap financial performance measures, e.g., EBITDA, EBITDA margin, adjusted
More informationartnet AG Quarterly Interim Statement for the First Quarter of 2017 artnet AG Quarterly Interim Statement for the First Quarter of 2017
Quarterly Interim Statement for the First Quarter of 2017 Quarterly Interim Statement for the First Quarter of 2017 Table of Contents General Information and Business Activities Economic Development of
More informationExhibitor Opportunities
7 th July 2018 Glasgow University, Wolfson Medical Building, Yudowitz Room and Atrium Exhibitor Opportunities Meet the LDN Community ABOUT THE EVENT Low-Dose Naltrexone (LDN) is quickly becoming established
More information서울대학교암연구소 2 층이건희홀 2010년 4월 23일박재범. Springer 한국지사장
Open Access 활성화방안 - 제 3차한국메들라스센터이용자그룹세미나 - 서울대학교암연구소 2 층이건희홀 2010년 4월 23일박재범. Springer 한국지사장 2 목차 1. 학술출판의의미 2. Open Access 현황 3. Open Access with Publisher 4. Open Access 활성화방안 3 학술출판의의미 학술출판의 Part..
More informationNational Health Reference Price List: Draft changes for Version 2.06
Private Bag X34, HATFIELD, 0028 Hadefields Block E, 1267 Pretorius Street, HATFIELD Phone: +27 (0) 12 431-0500 Fax: +27 (0) 12 430-7644 Http://www.medicalschemes.com To: All medical schemes, administrators,
More informationAccess Points: Frequently Asked Questions 15 June 2016
Access Points: Frequently Asked Questions 15 June 2016 Access Point Interim Agreement Q. Why have I received an Interim Agreement? The Commonwealth and Diabetes Australia have entered into a new NDSS Agreement
More informationNational Bank 8th Annual Quebec Conference TSX: IMV. May 30, IMV Inc. All rights reserved.
National Bank 8th Annual Quebec Conference TSX: IMV May 30, 2018 Forward-looking Statements Except for historical information, this presentation contains forward-looking statements, which reflect IMV Inc.
More informationOncolytics Biotech Inc. Announces Third Quarter 2010 Results
November 10, 2010 Oncolytics Biotech Announces Third Quarter 2010 Results CALGARY, Nov. 10 /PRNewswire-FirstCall/ - Oncolytics Biotech (TSX:ONC, NASDAQ:ONCY) ("Oncolytics" or the "Company") today announced
More informationMedia kit. Highly Targeted Digital Marketing to Respiratory Care and Sleep Medicine Professionals
2018 RTSleepWorld Media kit Highly Targeted Digital Marketing to Respiratory Care and Sleep Medicine Professionals RTSleepWorld 2018 Media Kit www.rtsleepworld.com 2 Our Digital Universe RTSleepWorld offers
More informationJOHN GEORGE PAVILION
JOHN GEORGE PAVILION PSYCHIATRIC EMERGENCY SERVICES (PES) CAPACITY ISSUES: Causes and Potential Solutions SYSTEM UPDATE Board of Supervisors Health Committee September 26, 2016 Rebecca Gebhart, Interim
More informationEast Region Committee Event. Mindfulness and Wellbeing. with Scott McInnes and Suzanne Donohoe. Welcome
East Region Committee Event Mindfulness and Wellbeing with Scott McInnes and Suzanne Donohoe Welcome 10 June 2015 Scott McInnes Internal Communications & Engagement, AIB 2 OBJECTIVES WHAT DO WE WANT THIS
More informationAsset tracing in the British Virgin Islands
Asset tracing in the British Virgin Islands 21 JANUARY 2011 Niki Olympitis PARTNER US C ATE GOR Y: ARTI C LE Helping you obtain information Knowledge and human power are synonymous, since ignorance of
More informationExhibit 2 RFQ Engagement Letter
Exhibit 2 RFQ 17-25 Engagement Letter The attached includes the 6 page proposed engagement letter to be used by HCC. ENGAGEMENT LETTER Dear: [Lead Counsel/Partner] We are pleased to inform you that your
More informationThe Accessible Information Standard - guidance for practices
The Accessible Information Standard - guidance for practices The Accessible Information Standard guidance for practices The Accessible Information Standard (AIS) known officially as SCCI1605 Accessible
More informationSeasonality of influenza activity in Hong Kong and its association with meteorological variations
Seasonality of influenza activity in Hong Kong and its association with meteorological variations Prof. Paul Chan Department of Microbiology The Chinese University of Hong Kong Mr. HY Mok Senior Scientific
More informationPrimary Care Commission Study Visit. 26 March 2015
Primary Care Commission Study Visit 26 March 2015 1 Agenda 1. How we got to where we are? 2. Suffolk GP Federation 3. North East Essex diabetes service 4. Working at scale issues and challenges 2 1. How
More informationAn Updated Approach to Colon Cancer Screening and Prevention
An Updated Approach to Colon Cancer Screening and Prevention Kevin Liebovich, MD Director for Quality for Gastrointestinal diseases Advocate Condell Medical Center Colon Cancer Screening and Prevention
More informationSingapore s Progress on GLP and MAD
2010/SOM1/CD/WKSP/025 Agenda Item: Afternoon Session I Singapore s Progress on GLP and MAD Submitted by: Singapore Case Study Workshop on the Chemicals Sector - From Principles to Practice Hiroshima, Japan
More informationBetter Diagnostics for Life
NASDAQ: NMRD Better Diagnostics for Life Corporate Presentation December 2018 Forward-Looking Statement This presentation includes forward-looking statements that are subject to many risks and uncertainties.
More informationSleep Market Panel. Results for June 2015
Sleep Market Panel Results for June 2015 Notes: o This is a monthly trending report of panel member data along with additional analysis by: Sleep labs affiliated with Hospitals vs. Independent Labs o Hospital
More informationINVESTOR PRESENTATION
INVESTOR PRESENTATION May 2018 2 FORWARD-LOOKING INFORMATION The following presentation contains statements that are considered forward-looking information ( FLI ) within the meaning of securities regulation.
More informationStorage Experiments of Extra Virgin Olive Oils from the Discounter
Storage Experiments of Extra Virgin Olive Oils from the Lothar Börs, Christoph Sippel, Nadja Liebmann Oktober 08 www.eurofins.com 1 Agenda Data and Facts about Eurofins Results of the Storage Test Conclusion
More informationStallings, Kristy. Kristy,
Stallings, Kristy From: Sent: To: Cc: Subject: Attachments: Keith Copaken Wednesday, February 08, 2012 9:18 AM Stallings, Kristy 'Snyder, John L.'; 'Jeff DeGasperi'; MSchlup TDD Exec Summary for FAED Submittal
More informationCorporate Presentation 1Q18. New growth cycle and value innovation
Corporate Presentation 1Q18 New growth cycle and value innovation Index 1 Dental benefits: an incipient sector in Brazil 2 Inside OdontoPrev 3 Sustainability 4 Strategic competitive advantages 5 Financial
More informationNew Payments Architecture Design Hub. Payments Strategy Forum 30th January 2017
New Payments Architecture Design Hub Payments Strategy Forum 30th January 2017 Summary The NPA Design Hub has been established to progress the detailed design of the NPA before handover to the NPSO. Our
More information2018 Media Kit JOURNALS CLASSIFIED ADVERTISING. Table of Contents Click the links above to jump to the desired page
JOURNALS CLASSIFIED ADVERTISING 2018 Media Kit Journal of Clinical Oncology (JCO) serves its readers as the single most credible, authoritative resource for disseminating significant clinical oncology
More informationLocal Improvement Scheme (LIS) 2016/17 Local Service for Dementia Care in East Lancashire GP Practices
Local Improvement Scheme (LIS) 2016/17 Local Service for Dementia Care in East Lancashire GP Practices CONTENT Page number 1. Introduction 2 2. 5 key elements of the Dementia LIS 3 Practice Awareness Practice
More informationSilicon Valley Chapter of IFMA
Silicon Valley Chapter of IFMA Award of Excellence Winner: Web Communications, 2013 Best Large Chapter, 2012 Professional Development, 2011 2014 Sponsorship Opportunities (Application Form on last page)
More informationFrom Analytics to Action
From Analytics to Action Overview So, what are we talking about here? How to make incremental changes to your digital content that will result in positive user actions Overview Rooted in the hard sciences
More informationAlberta - US Comparator: Standard-Making and Enforcement Functions
Alberta - US Comparator: Standard-Making and Enforcement Functions Current Reliability Standards Below is a link to current reliability standards in Alberta: http://www.aeso.ca/rulesprocedures/17006.html
More informationOur research for you. German Equity Forum November 2011
Our research for you. German Equity Forum 21-23 November 2011 Disclaimer Certain statements in this communication contain formulations or terms referring to the future or future developments, as well as
More informationUNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 10-Q
10-Q 1 v402511_10q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT 1934. For the
More informationMarketing on a Budget: Monthly quit & win challenges to drive quitline utilization. Presenters: John Atkinson & Elizabeth Harvey
Marketing on a Budget: Monthly quit & win challenges to drive quitline utilization Presenters: John Atkinson & Elizabeth Harvey WHAT IS THE FIRST WEEK CHALLENGE? Monthly campaign Register online or by
More informationMARKET NEWS for pig meat
MARKET NEWS for pig meat Market analysis 4 April 2016 Week 14 MARKET SITUATION Europe: Pork legs and other cuts were traded at largely unchanged prices this week. UK: the bacon market is stable. Third
More informationMy VeriSTAR & Veristar Info: The all-in-one portal for Marine professionals
My VeriSTAR & Veristar Info: The all-in-one portal for Marine professionals My VeriSTAR mobile application Veristar Info website Monitor your fleet Plan your surveys Stay informed, anytime, anywhere Manage
More informationUK SMART Recovery Partnership Scheme
UK SMART Recovery Partnership Scheme Contents What is SMART Recovery?... 3 Why Partner with UK SMART Recovery?... 3 What are the Intended Outcomes?... 3 Key Points... 4 Partnership Conditions... 4 Registration
More informationXXII: CTP Summarizes Scientific Case for Limiting Nicotine in Cigarettes. Company Update October 15, 2018 Industrial & Consumer Technology
Company Update Industrial & Consumer Technology (XXII - $2.81 - Buy) COMPANY NOTE JAMES McILREE, CFA, Senior Research Analyst, +1-646-465-9034 jmcilree@chardan.com Sales and trading 7 a.m. to 7 p.m. ET,
More informationConsultancy Support Services for the Procurement of LEU for the establishment of the IAEA LEU Bank
Statement of Work Services for the Procurement for the establishment of the IAEA LEU Bank 14 June 2016 Page 1 of 8 Statement of Work (SOW) Market Research and Procurement - 1. Introduction... 3 2. General
More information